humanized antibodies – image credits Wikipedia

 
NOVEMBER 2015 – Pradaxa patients may have a better chance of surviving emergency surgeries, due to a recent study using 5g of idarucizumab (humanized antibody fragments). In critical cases, such as patients with uncontrolled bleeding, intracranial hemmorrhage, or severe trauma following an automobile accident, there is a marginally improved chance for the patient to survive invasive procedures. The specific study mentioned that the timing of the treatment is crucial, such as administering the anticoagulant within four hours. Normal results occurred 92% of the time, under controlled circumstances in the study from Boehringer Ingelheim. Results of the study were presented at the European Society of Cardiology Congress 2015.
 
Legal Commentary
Our Pradaxa attorneys at Fears Nachawati are studying, examining and investigating current Pradaxa claims on behalf of patients and their families who may have been injured by the drug. If you or a loved one has experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.694.6774 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Pradaxa Lawyer who is focused on representing victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous medication cases successfully, with proven results, such as seven and eight figure confidential settlements. Texas Monthly Magazine recognized Mr. Nachawati as a Super Lawyer for the past six years. He is a member of many prominent legal organizations, including: the Grievance Committee for the State Bar of Texas, Board of Directors of the Texas Trial Lawyers Association, Board of Directors for Public Justice, PAC member of the American Association for Justice, a Leaders’ Forum, and the Million Dollar Advocates Forum. Mr. Nachawati is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Contact Majed Nachawati through his website http://bloodthinnerlawfirm.com, by email at mn@fnlawfirm.com or by calling +1.866.694.6774

NOVEMBER 2015 – Four trial dates are set for early 2017 for the consolidated multidistrict litigation (MDL) against Bayer AG and a Johnson and Johnson subsidiary regarding injuries sustained by Xarelto patients. U.S. District Judge Eldon Fallon in the Eastern District of Louisiana issued the order for trial dates of February 6, 2017 and March 13, 2017. Mississippi’s Xarelto trials will be held on April 24, 2017. In Texas, the Xarelto trial will occur on May 30, 2017. The MDL allows the large number of individual cases of Xarelto injuries to benefit from certain streamlined class action processes, without becoming a class, including pre-trial motions, discovery, and settlement conferences. All plaintiffs will reap the benefits of all of the available evidence. The consolidated lawsuits allege that Xarelto causes severe internal bleeding, serious injuries, and death.

 
Legal Commentary
Fears Nachawati’s Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders’ Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

 

NOVEMBER 2015 – Additional lawsuits filed this year in Ohio and Pennsylvania allege that the blood thinner drug Xarelto is causing serious injuries and death to patients nationwide. Xarelto has been proven to cause complications, such as: excessive bleeding, red or black stools, frequent nosebleeds, pink or brown urine, unexplained bruises, bruises that increase in size, coughing up blood or blood clots, vomiting blood or vomit that resembles coffee grounds, bleeding from the gums, excessive menstruation and death. The Xarelto lawsuits are planned for multidistrict litigation in 2017 in the US District Court, Eastern District of Louisiana. The Ohio case was filed on October 5 and the Philadelphia case was filed October 8. 
 
Legal Commentary
Fears Nachawati’s Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders’ Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

 

OCTOBER 2015 – Although there is still no antidote for Xarelto or Eliquis, the European Medicines Agency (EMA) is fast-tracking Praxbind as an antidote for the blood thinner Pradaxa. Pradaxa patients have been injured and dying due to the anticoagulant causing uncontrollable bleeding in emergencies. The life-threatening risk of uncontrolled bleeding is a constant threat to Pradaxa patients. The Committee for Medicinial Products for Human Use (CHMP) recommended marketing authorization after its rapid assessment of Praxbind. The study resulted in reveral of Pradaxa’s anticoagulant effect 5 minutes after the patients in the Praxbind drug study took the antidote.
 
 
Legal Commentary
Fears Nachawati’s Pradaxa attorneys are studying, examining and investigating Pradaxa claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Pradaxa Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders’ Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at bloodthinnerlawfirm.com, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

 

OCTOBER 2015 – Many Xarelto lawsuits that have been filed against Johnson & Johnson and Bayer Corporation allege that the pharmaceutical companies failed to disclose the reality of the blood thinner’s risks and dangers. Xarelto has been prescribed as a blood thinner to treat many conditions, from nonvalvular atrial fibrillation, deep vein thrombosis, to pulmonary embolism. The favorable studies that center on the drug’s positive outcomes are also at question, due to the many cases of uncontrolled bleeding that sometimes lead to death in Xarelto patients nationwide. Other patients have suffered strokes, retinal hemorrhages, epidural hematoma, intracranial hemorrhages, hemoglobin decrease, gastrointestinal hemorrhages, and adrenal bleeding.
 
Legal Commentary
Fears Nachawati’s Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders’ Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.
 

 

OCTOBER 2015 – Last month, Huffington Post published a 58,000 word series on Johnson & Johnson’s illegal marketing of the dangerous drug Risperdal. Risperdal is proven to cause young boys to grow large breasts. The series exposes unethical and illegal behavior from Johnson and Johnson since Risperdal’s release in 1994. We can all take steps to ensure that Johnson & Johnson is accountable for manufacturing and selling dangerous drugs. As an informed consumer, each one of us can avoid drugs produced by such companies, who have long histories of questionable methods. Read the labels of all drugs, both prescription drugs and over-the-counter drugs. Ask your doctor about other options for drugs that are not promoted or sold by companies that have outstanding litigation. Most importantly, you can bring these issues to light in litigation by filing a lawsuit when you or one of your loved ones is harmed by a dangerous drug.
 
Legal Commentary
The antipsychotic drug Risperdal has been linked to breast development in young boys. Psychopharmacology published first study results in January 1999, associating Risperdal with gynecomastia. The study reported Risperdal caused gynecomastia when used in conjunction with the antidepressant Prozac, which contains fluoxetine. Patients who have developed Risperdal gynecomastia are encouraged to speak with an experienced pharmaceutical injury attorney immediately. Risperdal has been proven to cause breast development in young boys, or pituitary cancer and tumors. Other symptoms of Risperdal caused gynecomastia include pain, tenderness, or swelling of the breasts, and/or nipple discharge. Gynecomastia can be emotionally and psychologically damaging, and may require surgical correction. If you or a loved one took Risperdal to treat bipolar disorder, schizophrenia, or behavioral issues associated with autism, you may be entitled to cash compensation. Contact our team of attorneys today by email or phone at +1.888.545.7402 for a free evaluation of your case today.
 
About the Author
Majed Nachawati is a dedicated Risperdal Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders’ Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/gynecomastia, by email at mn@fnlawfirm.com or by calling +1.888.545.7402

 

OCTOBER 2015 – The Washington Post published an article recently reporting concerns that the FDA did not adequately review the safety and risks of the Pradaxa blood thinner. Reports of Pradaxa injuries are coming in daily to our office, including an Indiana man who has been taking Pradaxa since 2013, and now has blood in his urine, a Vermont woman who took Pradaxa since 2011 and now has internal bleeding, and a Michigan woman who took Pradaxa since 2014 and developed uncontrolled internal bleeding less than a year later. The Post’s article explained how the Project on Government Oversight (POGO) is investigating to determine if the warnings provided to patients were adequate. The article concluded that two members of the FDA advisory committee that made decisions regarding FDA approval of Pradaxa are partnered financially with Boehringer Ingelheim, Pradaxa’s manufacturer.
 
Legal Commentary
Fears Nachawati’s Pradaxa attorneys are studying, examining and investigating Pradaxa claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Pradaxa Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders’ Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at bloodthinnerlawfirm.com, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

 blood thinner Xarelto causes uncontrollable bleeding and death in many Xarelto patients

OCTOBER 2015 – Jasnssen Pharmaceuticals, Inc. published a recent study on the safety of Xarelto, where the drug manufacturer attempted to minimize the injuries and uncontrolled bleeding that Xarelto patients are suffering globally. Over 45,000 patients participated in the study. Janssen and the marketing firm that assisted with the study concluded that almost 3 out of 100 Xarelto patients experienced major bleeding. Our reports show that the issues with bleeding hemorrhaging, stroke, and death are critical, and should not be understated.
 
Just this week, we have heard from the following individuals regarding their personal struggles after taking Xarelto. Even worse, we hear daily from the loved ones of former Xarelto patients who lost their battle with uncontrolled bleeding and died after taking the blood thinner.
 
The top five most recent reports include:
 
  • A Louisiana woman who took Xarelto 6 months, and then she began uncontrollable bleeding from her rectum
  • A California woman who had to be hospitalized from excessive bleeding after taking Xarelto
  • A Texas man who developed blood in his urine and internal bleeding from Xarelto use
  • A Wisconsin woman who died from internal bleeding after taking Xarelto
  • A Texas woman who suffered from a stroke after taking Xarelto
 
Legal Commentary
Fears Nachawati’s Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders’ Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

SEPTEMBER 2015 – Huffington Post has published "The Miracle Industry Series," where the news outlet reveals that Johnson & Johnson spent 20 years marketing the drug Risperdal to children and the elderly. Once again, pharmaceutical profits won out over safety and the truth about the side effects. Huffington Post reveals that Johnson & Johnson’s "strategies, tactics, and mindset should make us wonder about the prescription drugs that are so much a part of our lives." Chapter 15 of the series is due to be released on September 29, 2015. Chapter 1 starts here: http://highline.huffingtonpost.com/miracleindustry/americas-most-admired-lawbreaker/chapter-1.html
 
Legal Commentary
The antipsychotic drug Risperdal has been linked to breast development in young boys. Psychopharmacology published first study results in January 1999, associating Risperdal with gynecomastia. The study reported Risperdal caused gynecomastia when used in conjunction with the antidepressant Prozac, which contains fluoxetine. Patients who have developed Risperdal gynecomastia are encouraged to speak with an experienced pharmaceutical injury attorney immediately. Risperdal has been proven to cause breast development in young boys, or pituitary cancer and tumors. Other symptoms of Risperdal caused gynecomastia include pain, tenderness, or swelling of the breasts, and/or nipple discharge. Gynecomastia can be emotionally and psychologically damaging, and may require surgical correction. If you or a loved one have taken Risperdal to treat bipolar disorder, schizophrenia, or behavioral issues associated with autism, you may be entitled to cash compensation. Contact our team of attorneys today by email or phone at +1.888.545.7402 for a free evaluation of your case today.
 
About the Author
Majed Nachawati is a dedicated Risperdal Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders’ Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/gynecomastia, by email at mn@fnlawfirm.com or by calling +1.888.545.7402

 

SEPTEMBER 2015 – Although the U.S. FDA approved Xarelto in 2011, many patients have experienced liver injuries and uncontrolled bleeding, resulting in severe damage and even death in some cases. In August, 2015, Canadian regulators announced an official investigation into numerous reports of liver injuries due to Xarelto use. The report states, "This issue was identified after two publications in the scientific literature described liver injury linked to the use of XARELTO in a total of 16 patients." Canada is not far behind the U.S. in its assessment of the health risks associated with Xarelto use.
 
Legal Commentary
Fears Nachawati’s Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders’ Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto by email at mn@fnlawfirm.com or by calling +1.866.813.1662.